bleomycetin has been researched along with Carcinoma, Squamous Cell in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, D; Chu, YX; Zhang, J; Zheng, A | 1 |
| Gao, WX; Nie, DB; Wang, CK; Wang, JF; Zhang, ZM | 1 |
| Sun, ML; Wang, CM; Wen, YM | 1 |
| Chen, J; Chen, SX; Dai, LN; Feng, Y; Li, XY; Liu, YR; Wang, H; Zhang, P; Zhou, CC | 1 |
| CHEN, XD; LÜ, WG; QIN, JL; SHI, HY | 1 |
| Gong, L; Liu, H; Lou, JY; Peng, ZL; Wang, P; Zhang, JW | 1 |
| Gong, JH; Li, Y; Liu, XJ; Zhen, YS | 1 |
| Gu, Y; He, Z; Peng, B; Yi, S; Zheng, G | 1 |
| Chen, FJ; Guo, ZM; Hua, H; Wu, GH; Xu, GP; Yang, AK; Zeng, ZY; Zhang, Q | 1 |
| Chou, MY; Tai, KW; Yang, JJ; Yang, LC; Yang, SH | 1 |
| Li, LJ; Sun, ML; Wang, CM; Wang, XY; Wen, YM | 1 |
| Chen, CJ; Zhang, ZY | 1 |
| Dai, Y; Liu, XJ; Zhen, YS | 1 |
| Chen, ZM; Jiang, Y; Qiu, XH; Yang, YX; Zhang, SQ | 1 |
| Chang, YC; Ho, YC; Tai, KW | 1 |
| Chebotareva, LI; Garin, AM; Guznov, GI; Moroz, LV; Prorokov, VV | 1 |
| Borisov, VI; Dvorkina, SIu; Ivanova, VG | 1 |
| Cai, HY | 1 |
| Choudhury, AK; Hecht, SM; Tao, ZF | 1 |
| Andreev, VG; Filippov, KG; Kurpeshev, OK; Lopatin, VF; Mardynskiĭ, IuS; Shaimbetov, BO | 1 |
| Huang, J; Wu, SY; Zhang, ZH; Zhen, YS | 1 |
2 trial(s) available for bleomycetin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
[Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Proportional Hazards Models; Remission Induction; Survival Rate | 2006 |
[Adjuvant chemotherapy with carminomycin and bleomycetin after radical surgery for squamous cell carcinoma of the lung (preliminary communication)].
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Carubicin; Clinical Trials as Topic; Daunorubicin; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nausea; Vomiting | 1982 |
19 other study(ies) available for bleomycetin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
[An exploration of the expression of MK and MVD in cervical cancer tissues before and after NACT].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cytokines; Female; Humans; Microvessels; Middle Aged; Midkine; Neoadjuvant Therapy; Neovascularization, Pathologic; Uterine Cervical Neoplasms; Young Adult | 2008 |
[Expression of X-linked inhibitor of apoptosis protein in Tca8113 cell and its relationship to chemoresistance].
Topics: Apoptosis; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; X-Linked Inhibitor of Apoptosis Protein | 2010 |
[Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Topics: Antibiotics, Antineoplastic; Bleomycin; Carbon; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Humans; In Vitro Techniques; Mouth Neoplasms; Nanoparticles | 2010 |
[The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mouth Neoplasms; Salicylates | 2010 |
[Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Vincristine; Young Adult | 2011 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hysterectomy; Ifosfamide; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; ErbB Receptors; Esophageal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2012 |
Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Topics: Animals; Antibiotics, Antineoplastic; Antibody Specificity; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Fluorouracil; Humans; Hydrophobic and Hydrophilic Interactions; Immune Sera; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Protein Binding; Proteins; Recombinant Fusion Proteins | 2012 |
[Role of induction chemotherapy with bleomycin A5 in treating stage T2 tongue squamous cell carcinoma].
Topics: Adult; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Male; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tongue Neoplasms | 2002 |
MEK inhibition enhances bleomycin A5-induced apoptosis in an oral cancer cell line: signaling mechanisms and therapeutic opportunities.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Cell Nucleus; Cell Survival; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; KB Cells; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mouth Neoplasms; Signal Transduction | 2004 |
[Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Topics: Antibiotics, Antineoplastic; Bleomycin; Carbon; Carcinoma, Squamous Cell; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Nanoparticles; Neck | 2004 |
[Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
Topics: Animals; Apoptosis; Bleomycin; Carcinoma, Squamous Cell; Drug Implants; Humans; Injections, Intralesional; Mice, Nude; Polymers | 2005 |
[Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Collagen Type IV; Female; Humans; Immunoconjugates; Liver Neoplasms, Experimental; Mice; Molecular Weight; Mouth Neoplasms; Neoplasm Transplantation | 2006 |
Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Survival; DNA Fragmentation; Drug Synergism; Flow Cytometry; Humans; KB Cells; Mouth Neoplasms; Verapamil | 2007 |
[Preliminary results of clinical evaluation of antineoplastic antibiotic bleomycetin].
Topics: Bleomycin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Hodgkin Disease; Humans; Nausea; Uterine Cervical Neoplasms; Vinblastine; Vomiting | 1982 |
[Establishment and application of transplantable models of human esophageal carcinoma in nude mice].
Topics: Animals; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Models, Animal; Esophageal Neoplasms; Fluorouracil; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation | 1993 |
Synthesis and DNA cleavage activity of a novel bleomycin A(5) glycoconjugate.
Topics: Bleomycin; Carcinoma, Squamous Cell; Catalysis; DNA; Humans; Liver; Molecular Structure; Plasmids; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
[Combined radiomodification in the treatment of patients with disseminated laryngeal cancer].
Topics: Adult; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Glucose; Humans; Hyperthermia, Induced; Laryngeal Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Remission Induction | 1990 |
[Inhibitory effect of pingyangmycin on human nasopharyngeal cancer transplanted in nude mice].
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Squamous Cell; Cell Line; Female; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation | 1986 |